MRK — Merck & Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual balance sheet for Merck & Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	8,096	13,192	7,093	13,689	14,565
Net Total Accounts Receivable
Net Total Receivables	9,230	10,110	11,072	11,119	12,691
Total Inventory
Total Other Current Assets
Total Current Assets	30,266	35,722	32,168	38,782	43,516
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	19,279	22,768	24,488	25,149	26,823
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	105,694	109,160	106,675	117,106	136,866
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	23,872	24,239	25,694	28,420	28,327
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	67,510	63,169	69,094	70,793	84,260
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	38,184	45,991	37,581	46,313	52,606
Total Liabilities & Shareholders' Equity	105,694	109,160	106,675	117,106	136,866
Total Common Shares Outstanding